Ulonivirine and Methadone Interaction Study in Healthy Adults
Treatments studied
This research study tests how a new drug called ulonivirine works with methadone in people who are stable on methadone treatment. The goal is to understand if these two medications can be safely used together without problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are in overall good health with no serious medical conditions
- Your body mass index (BMI, a measure of weight relative to height) is between 18 and 40
- You have been on a stable, unchanged dose of methadone for at least 2 weeks before starting the study
- You have been reliably attending your methadone maintenance program for at least 2 months
- You have not had cancer in the past
- You do not have a history of severe allergies or bad reactions to medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests how ulonivirine (a new medicine) behaves and is tolerated in people who have stable, mild-to-moderate liver impairment from chronic liver disease. The goal is to understand safety and drug handling in this specific liver condition.
This study checks how a new hepatitis C medicine (bemnifosbuvir/ruzasvir) interacts with medications used for opioid addiction, such as buprenorphine/naloxone or methadone. It helps doctors understand if the new medicine is safe and effective for people taking these addiction treatments.
This early study tests how a person’s genetic makeup may change how fast certain medicines move through the body. It compares drug levels when combined with methadone and tizanidine, aiming to understand safer dosing and effects.
This study sees if it's safe to switch your current HIV medication to a two-pill combo (dolutegravir and lamivudine) if you are also taking medication for opioid addiction. It aims to make treatment simpler and more convenient.
This trial tests two new HIV medications, islatravir and ulonivirine, in people who have never taken HIV treatment before. It aims to see if this combination can safely control the virus.
This is an early-stage safety study testing a new investigational drug (VH4770359) in healthy volunteers. Researchers want to understand how the body processes the drug and ensure it is safe and well-tolerated.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.